IN THE SPOTLIGHT

Cancer Grand Challenges Summit 2024: No Time to Waste in Addressing Some of Toughest Challenges in Cancer

Cancer Grand Challenges Summit 2024: No Time to Waste in Addressing Some of Toughest Challenges in Cancer

Read time: 4 minutesI just returned from the Cancer Grand Challenges Summit, held March 5–8, 2024 in London, England. Cancer Grand Challenges was launched in 2020 as a collaboration between Cancer Research UK and the National Cancer Institute in the US, whereby they provide $25 million to international, multi-institutional teams working to address some of the most perplexing issues in the cancer field. I am LUNGevity’s representative on Team CANCAN, which is working to understand and treat…

General Virtual Meetup

General Virtual Meetup

For patients/survivors - Join us every Tuesday for this general meetup for those impacted by lung cancer.Register in advance for this meeting:After registering, you will receive a confirmation email containing information about joining the meeting.

Leveraging Genetics to Understand Why Younger Adults Are Developing Lung Cancer

Leveraging Genetics to Understand Why Younger Adults Are Developing Lung Cancer

Read Time: 5 minutesIt’s a mystery that has been baffling researchers: Why do some people develop lung cancer in their 20s or 30s? While we used to think lung cancer was only caused by exposure to tobacco and environmental factors like radon, researchers are starting to learn that the development of lung cancer, particularly in younger adults, could have a hereditary component.  LUNGevity partnered with the Lung Cancer Initiative, a leading nonprofit in North Carolina, to support…

FDA Awards Breakthrough Therapy Designation to Novel HER2-Activating NSCLC Therapy

FDA Awards Breakthrough Therapy Designation to Novel HER2-Activating NSCLC Therapy

FDA Grants Breakthrough Therapy Designation to BAY 2927088 for HER2-Mutated NSCLC

FDA Grants Breakthrough Therapy Designation to BAY 2927088 for HER2-Mutated NSCLC

Fertility Preservation and Cancer

Fertility Preservation and Cancer

Medications and treatments for lung cancer can affect fertility in both women and men. This video covers how to work with a reproductive endocrinologist, the first steps after getting your diagnosis, what to consider before starting treatment, and options after completing treatment.

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review

Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer

Lung Cancer Masterclass: Get Smart About Lung Cancer

Lung Cancer Masterclass: Get Smart About Lung Cancer

In the past five years, the lung cancer community has seen an astonishing number of new treatments. As our understanding of lung cancer has deepened, the older treatment approaches have also become more effective and efficient.  These options are fantastic steps toward improving the overall survival and quality of life for people living with lung cancer, but it can be difficult for patients and caregivers to keep track of the new drug treatments and scientific advancements. …

HOPE Summit 2024 in Atlanta, GA

HOPE Summit 2024 in Atlanta, GA

Atlanta, GA

Registration is now open for patients, caregivers, and their families! Join us for this free event in Atlanta, GA, May 3-5, 2024.HOPE Summit is a unique weekend conference for people living with lung cancer, survivors, and caregivers to learn how to manage and navigate aspects of everyday life with lung cancer while building their community of support.  The conference features inspirational speakers and key experts on practical issues of cancer survivorship. Sessions will cover many of the…

Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001

Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001

Dr Mark Socinski on How Targeted Therapies Have Impacted Lung Cancer Outcomes

Dr Mark Socinski on How Targeted Therapies Have Impacted Lung Cancer Outcomes

ROS1-Positive NSCLC Represents a Targetable Mutation for New Therapies

ROS1-Positive NSCLC Represents a Targetable Mutation for New Therapies

Repotrectinib May Serve as a New Standard of Care Across Treatment Lines in ROS1+ NSCLC

Repotrectinib May Serve as a New Standard of Care Across Treatment Lines in ROS1+ NSCLC

Questions to Ask About Clinical Trials

Questions to Ask About Clinical Trials

Asking your doctor and medical team questions about clinical trials is a helpful way to decide if they are a good fit for you. You may already have some in mind, but a few basic questions to ask and get answered before making a decision are:Do you know of any clinical trials for my type and stage of lung cancer?What are the benefits and risks of this clinical trial?What are the eligibility guidelines?How long does the study last?Will you still be in charge of my care?What are the costs, and…

Clinical Trial Phases

Clinical Trial Phases

The four phases of lung cancer clinical trials each serve a different and important purpose. From testing the safety of a new treatment to its effectiveness and long-term outcomes, this short video explains how researchers use clinical trials for new lung cancer treatments.Phases of a Clinical Trial:1. Safety of the new treatment 2. Does the cancer respond to the treatment 3. Is this new treatment better than the current options 4. Studies the long-term benefits and side effects

Helpful Apps for People Living with Cancer

Helpful Apps for People Living with Cancer

As mobile apps become more ingrained in our lives, it’s natural to look for ones that can help manage a cancer diagnosis. As for which app to choose, it really comes down to what you’re looking for, what you’re comfortable with, and what fits your needs.  This list of helpful apps for people living with cancer includes ones that range from very basic, essentially a mobile pen and piece of paper, to all-in-one solutions that make medication tracking, document management, and…

Repotrectinib is Now FDA-Approved to Treat Patients with ROS1-positive NSCLC

Repotrectinib is Now FDA-Approved to Treat Patients with ROS1-positive NSCLC

On November 15, 2023, the US Food and Drug Administration (FDA) announced the approval of repotrectinib to treat patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).  Repotrectinib is part of a class of drugs called tyrosine kinase inhibitors, or TKIs, which have been beneficial for many patients with oncogene-driven lung cancers. TKIs are a type of therapy that specifically targets changes in genes that are known to promote tumor growth.…

LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards

LUNGevity Announces $1.2M in Lung Cancer Workforce Development Research Awards

LUNGevity Foundation is proud to announce the recipients of four awards to bolster the lung cancer research workforce— the Career Development Award, the VA Research Scholar Award, the Health Equity and Inclusiveness Research Fellow Award, and the ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant.“Progress in lung cancer research is only possible with a vibrant and diverse thoracic oncology workforce,” notes Upal Basu Roy, PhD, MPH, executive director, LUNGevity Research. “We…

Finding (Mental) Peace this Holiday Season

Finding (Mental) Peace this Holiday Season

The holidays are stressful enough without having to deal with lung cancer. LUNGevity is here to help.This discussion of the mental health challenges we face in the lung cancer community includes strategies for coping with a lung cancer diagnosis, stigma, and holiday anxiety. With the daylight getting shorter, we also discuss tips to address seasonal affective disorder. The free support programs and services available through LUNGevity for patients and caregivers are highlighted.This webinar…

FDA Approves Repotrectinib for ROS1-Positive NSCLC

FDA Approves Repotrectinib for ROS1-Positive NSCLC

FDA Approves Next-Generation Tyrosine Kinase Inhibitor Repotrectinib for ROS1-Positive NSCLC

FDA Approves Next-Generation Tyrosine Kinase Inhibitor Repotrectinib for ROS1-Positive NSCLC

Treatment & Research Takeaways: ESMO 2023 Meeting

Treatment & Research Takeaways: ESMO 2023 Meeting

The European Society for Medical Oncology (ESMO) recently held its annual conference from October 20 – 24, 2023 in Madrid, Spain. ESMO represents one of the largest gatherings of the international oncology community, and this year’s meeting had over 30,000 registered attendees from around the world.  Though October 19th brought record rainfall to Madrid, breaking a 100-year record, the rain in Spain didn’t dampen the palpable excitement of this year’s meeting. This was an especially…

What Is a Clinical Trial

What Is a Clinical Trial

Lung cancer clinical trials are carefully designed research studies to evaluate and learn more about new drugs and treatments. They give people the ability to participate in lung cancer research and access to new treatments that otherwise may not be available to them, all under the close supervision of medical experts. 

Watch Recorded Expert Sessions From ILCSC

Watch Recorded Expert Sessions From ILCSC

The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference for people with lung cancer, caregivers, and advocates. The 2023 conference was held September 22-23.  The recorded sessions from this conference are available to registered participants through December 21, 2023, at www.lungevity.org/ilcsc. If you did not register for the conference but would like to view the recordings, you may still register for free access. The recordings are…

The Latest Lung Cancer Science: Highlights of WCLC 2023

The Latest Lung Cancer Science: Highlights of WCLC 2023

I had the privilege of attending the 2023 World Conference on Lung Cancer (WCLC) in Singapore with my colleague Dr. Bellinda King-Kallimanis. WCLC, the world's largest meeting dedicated to lung cancer and other thoracic malignancies, is an excellent forum for learning about the latest research into the early detection and treatment of lung cancer. Apart from the science, it was inspiring to see fellow advocates and network with brilliant researchers, all razor-focused on improving the outcomes…

Lung Cancer and NCCN Guidelines: What They Are and Why They Matter

Lung Cancer and NCCN Guidelines: What They Are and Why They Matter

In this expert meetup session, Carlin Callaway will review the National Comprehensive Cancer Network’s (NCCN’s)  Non-Small Cell Lung Cancer (NSCLC) Guidelines and discuss how they are applicable to patient care. Participants will be able to ask general questions and engage in meaningful conversation.An expert in the field, Carlin Callaway, DNP, RN, ACNP-BC, ACNS-BC, AOCNP is Assistant Professor and the Lead Medical Oncology Advanced Practice Provider at the University of Colorado Cancer…

Be Part of the Largest Lung Cancer Event in the Nation

Be Part of the Largest Lung Cancer Event in the Nation

November is Lung Cancer Awareness Month, when the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong. You can get involved in raising awareness about lung cancer by joining LUNGevity on Saturday, November 4, 2023, for our nationwide walk, Breathe Deep TOGETHER. Thousands of people from across the country, coming together in a singular event, is a powerful way to make our voices heard and increase the visibility of lung cancer.Together…

Transportation to Treatment

Transportation to Treatment

At some point, transportation to appointments becomes a challenge for everyone. Whether it be the cost, time commitment, or finding reliable transportation, we share some tips for overcoming or avoiding these issues when they arise.

What's new in RET-positive lung cancer: Moving beyond tyrosine kinase inhibitors

What's new in RET-positive lung cancer: Moving beyond tyrosine kinase inhibitors

This recorded Facebook Live presentation features guest speakers Nicolas Le-Bel (caregiver and member of the RETpositive patient group) and Dr. Alex Drilon (Thoracic Oncologist & Early Drug Development Specialist at Memorial Sloan Kettering Cancer Center). Dr. Drilon is also a recipient of a 2022 Hamoui Foundation/LUNGevity Lung Cancer Research Award for RET-positive lung cancer. Thank you to the Hamoui Foundation for their partnership.